Healthcare Professionals - International
 
  

 
30-09-2008
Elekta commits to Supporting the Further Development of Advanced Health Care in Ukraine - donation of Brain Surgery System in the Presence of Her Majesty Queen Silvia of Sweden
Elekta, a global leader in advanced technology for treating cancer and brain disorders, today announced a donation of Leksell Stereotactic System® for minimally invasive brain surgery to the International Charitable Foundation "Ukraine 3000" for which Mrs. Kateryna Yuschenko, wife of the President of Ukraine is the prime guardian. This donation was presented in the presence of Her Majesty Queen Silvia of Sweden, founder of the World Childhood Foundation. The system will be used for treating a wide range of brain disorders at one of the leading neurosurgery hospitals in Ukraine.
Read More ...

 
30-09-2008
Wake Forest University Baptist Medical Center ramps up Cancer Treatment Capabilities with Stereotactic Systems from Elekta
Wake Forest University Baptist Medical Center (WFUBMC) has reinforced its ability to perform state-of-the-art stereotactic radiation medicine by adding Leksell Gamma Knife® Perfexion™ and Elekta Axesse™ to its range of treatment solutions.
Read More ...

 
22-09-2008
Clinicians in Odense, Denmark, first in Scandinavia to offer new Innovative Technology from Elekta for faster and more accurate Cancer Treatment
Odense University Hospital in Denmark has become the first Scandinavian cancer centre to choose Elekta VMAT (Volumetric intensity Modulated Arc Therapy) to expand the capabilities of the hospital’s radiation oncology department. The addition of this solution to the range of treatment techniques will provide physicians with the ability to treat cancer tumors with improved precision and accuracy, while at the same time significantly reduce treatment times.
Read More ...

 
18-09-2008
Elekta Extends its Line of Stereotactic Treatment Solutions at 2008 Congress of Neurological Surgeons Annual Meeting
CNS Booth #247 - Elekta, a leading provider of technology for treating cancer and neurological conditions, today introduced Extend*™, a new stereotactic treatment program that lets neurosurgeons and radiation oncologists apply the proven power and precision of Gamma Knife® surgery to an even broader class of targets in the head and neck.
Read More ...

 
18-09-2008
Thompson Cancer Survival Center to Take Concer Program to the Next Level With Purchase of Elekta Infinity Treatment System
Thompson Cancer Survival Center (TCSC, Knoxville, Tennessee) has placed an order for Elekta Infinity, reaffirming their long-term commitment to deliver the most advanced radiation therapy treatments. The addition of Elekta Infinity, a linear accelerator optimized for Volumetric Modulated Arc Therapy (VMAT) will complement the center’s decade-long plan to improve patient outcomes.
Read More ...

 
16-09-2008
Elekta Announces Availability of Elekta Infinity with VMAT Technology for Fast, More Precise Treatment of Cancer - Company unveils best-in-class treatment solutions at ASTRO’s 50th Annual Meeting
ASTRO Booth #601 -- Elekta, pioneering significant innovations and clinical solutions for cancer and neurological conditions, today announced new product offerings from the Elekta Group. Topping the list of innovations is Elekta Infinity; the company’s most advanced digital linear accelerator, now available to customers in the United States. Elekta Infinity increases speed and precision in delivering Volumetric Modulated Arc Therapy (VMAT), offering patients shortened treatment times with the highest degree of precision.
Read More ...

 
15-09-2008
CMS, Inc., An Elekta Company, Announces Commercial Availibility of Focal4D™
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced the commercial launch of its new 4D treatment planning solution, Focal4D™.
Read More ...

 
15-09-2008
Presbyterian Cancer Center to offer cancer patients high-end VMAT treatments with the installation of Elekta Infinity
Presbyterian Cancer Center – Dallas, a joint venture between Presbyterian Hospital of Dallas and Texas Oncology, PA, recently installed an Elekta Infinity system, enabling the facility to begin treating patients with Volumetric Modulated Arc Therapy (VMAT). Elekta Infinity is the facility’s first image guided linear accelerator, and will allow the Center to offer patients shortened treatment times with the highest degree of precision.
Read More ...

 
15-09-2008
Elekta announces next-generation radiation treatment technologies at ESTRO 27
Elekta, a human care company pioneering significant innovations and clinical solutions for cancer and brain disorders, are currently exhibiting several important innovations in radiation therapy and radiosurgery at the 27th annual meeting of ESTRO, The European Society for Therapeutic Radiology and Oncology.
Read More ...

 
29-08-2008
CMS, Inc., an Elekta Company, announces first cancer patients treated with Monaco™ radiation treatment planning system
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, announced that three sites have delivered clinical treatments utilizing Monaco™, its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application.
Read More ...

 
26-08-2008
Elekta receives CE mark clearance for ‘Everyday Radiation Therapy’ accelerator, Elekta Compact
Elekta recently announced that it has received CE mark clearance to distribute Elekta Compact™, the latest addition to its line of treatment systems, offering clinicians an easy to implement, more affordable solution for radiation therapy. CE Mark clearance from the European Union certifies Elekta Compact has met health, safety and environmental requirements for consumer safety.
Read More ...

 
22-08-2008
CMS, Inc., an Elekta Company, receives FDA 510(k) clearance for Atlas-Based Autosegmentation Software
CMS, Inc., an Elekta Company, and worldwide leader in radiation treatment planning and workflow management solutions, has received FDA 510(k) clearance for its new Atlas-Based Autosegmentation (ABAS) product. This clearance allows CMS to immediately begin distributing Atlas-Based Autosegmentation for clinical use in the United States.
Read More ...

 
12-08-2008
Skagit Valley Hospital Regional Cancer Care center enhances patient care with Elekta Axesse™
New Treatment Option for Patients with Tumors of the Brain, Spine and Body.
Read More ...

 
30-07-2008
Seattle's Swedish Cancer Institute first in U.S. to treat cancer patient with Elekta VMAT
A patient with pancreatic cancer recently became the first person in the United States to receive treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at Seattle's Swedish Cancer Institute. This revolutionary new technology dramatically decreases treatment times - delivering a higher dose to the tumor target without compromising coverage and patient safety.
Read More ...

 
25-07-2008
Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
The Elekta Family of Companies will showcase their unique line of cancer treatment solutions at the 2008 American Association of Physicists in Medicine (AAPM) annual meeting, demonstrating how the joint forces of Elekta, IMPAC and CMS are delivering cutting-edge radiation therapy planning and delivery solutions that streamline the treatment process to create a better experience for patients, as well as enhance clinician efficiency.
Read More ...

 
16-06-2008
Elekta VMAT 510(k) Clearance Welcomed by US Radiation Oncologists
Elekta has received FDA 510(k) clearances for its groundbreaking Elekta VMAT solution, allowing US cancer specialists to both plan and deliver radiation using a technique which has the potential to revolutionize the practice of radiation oncology. This news has been eagerly anticipated by US cancer clinics as it offers both significant benefits to their patients and the opportunity to increase patient volumes.
Read More ...

 
12-06-2008
Elekta Announce Global Launch of Innovative new Platform Developed to Provide a Clearer Understanding of Radiotherapy Solutions for the Treatment of Cancer
Elekta have created a 3-D Virtual Clinic which offers radiation therapists, administrators, patients and investors alike a unique opportunity to better acquaint themselves with Elekta’s products and solutions and how they are interconnected.
Read More ...

 
05-06-2008
Elekta and Mary Bird Perkins Cancer Center sign strategic Multi-Center Radiation Therapy Systems Agreement
Elekta, a world class leader in advanced radiation therapy and radiosurgery, has been selected to supply multiple Elekta Synergy® digital linear accelerator systems to Mary Bird Perkins Cancer Center over the next few years.
Read More ...

 
03-06-2008
San Antonio Community Hospital Commissions Leksell Gamma Knife® Perfexion™ to serve over 3 Million Californians
Physicians at California’s San Antonio Community Hospital in Upland, will soon treat patients using the new Leksell® Gamma Knife Perfexion™. A revolutionary alternative to traditional open-brain surgery and daily radiation treatments, Leksell Gamma Knife Perfexion, developed by the international medical technology group Elekta, delivers focused doses of radiation without making an incision to treat brain tumors and other brain disorders.
Read More ...

 
26-05-2008
Leksell Gamma Knife® Perfexion™ receives regulatory approval in Japan
The Japanese Ministry for Health, Labor and Welfare, MHLW, has given approval for Leksell Gamma Knife® Perfexion™, the world-leading clinical solution for non-invasive radiosurgical treatments of tumors, vascular malformations and other brain disorders. Elekta, the international medical technology group and developer of Gamma Knife® surgery, will now be able to deliver and install this advanced technology at new and existing customer sites in Japan.
Read More ...

 
21-05-2008
Elekta sees record attendance and record number of submitted abstracts at International Leksell Gamma Knife® Society Meeting in Quebec, Canada
At the 14th International Leksell Gamma Knife® Society Meeting on May 18-22, over 500 participants including neurosurgeons, radiation oncologists and other medical specialists using Leksell Gamma Knife for treatment of tumors and other brain disorders convened at the historic Château Frontenac Hotel in Quebec, Canada. During the meeting, 260 oral and poster presentations covered treatment of malignant and benign brain tumors, functional neurosurgery, imaging & biology as well as physics & technology. On Wednesday, May 21, the prestigious Pioneers in Radiosurgery Award was presented to John Flickinger, M.D., Professor of Radiation Oncology and Neurological Surgery at the University of Pittsburgh for his early pioneering work on prediction of complications following Gamma Knife® surgery.
Read More ...

 
19-05-2008
Australian Safety Agency orders Elekta Synergy® as gold standard for Calibration and Dosimetry
Elekta, world-leading provider of radiation therapy and radiosurgery solutions, is pleased to announce that the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) has joined other world-class physics standards centers with its order of an Elekta linear accelerator. ARPANSA will accept delivery of an Elekta Synergy® system this summer, and will utilize the Elekta system’s high level of stability for its national physics measurements.
Read More ...

 
02-05-2008
Elekta receives an order to deliver comprehensive suit of advanced cancer treatment technologies to new center in Sydney including the first Leksell Gamma Knife® to be installed in Australia
In a collaborative effort, Macquarie University, incorporating The Australian School of Advanced Medicine, together with Dalcross Private Hospital has launched an ambitious project to improve access to advanced radiosurgery and radiation therapy for patients in Sydney and across Australia’s New South Wales region. The medical technology group Elekta, based in Stockholm, Sweden, has been selected as the main provider of a comprehensive suit of cancer and neurosurgical treatment solutions and supporting IT systems to the new Macquarie University Private Hospital, currently under construction.
Read More ...

 
25-04-2008
Elekta announces first Linear Accelerator order in New Zealand
Elekta, a world leader in clinical solutions for radiosurgery and radiation therapy, has finalized its first-ever New Zealand order. Auckland Radiation Oncology Limited (ARO) have decided to invest in a new Elekta Synergy® system with MOSAIQ™ EMR and Elekta VMAT, for delivery in April.
Read More ...

 
11-03-2008
Elekta to supply Advanced Radiation Therapy Treatment Equipment to Prestigious Measurement Institution
Elekta is pleased to announce it has been selected to supply their Elekta Synergy® 3D IGRT Linear accelerator to The National Physical Laboratory. The National Physical Laboratory (NPL) is the UK’s National Measurement Institute and is a world-leading centre of excellence in developing and applying the most accurate measurement standards, science and technology.
Read More ...

 
04-03-2008
Elekta completes the acquisition of CMS
The international medical technology group Elekta AB (publ) (STO: EKTAb) today announced the completion of its announced acquisition of CMS, Inc. for total cash consideration representing an enterprise value of USD 75 M.
Read More ...

 
22-02-2008
Elekta chosen to deliver advanced 3-D Brain Mapping Technology as part of collaboration with leading French Brain Imaging Facility
Elekta has signed a contract to deliver Elekta Neuromag®, the world-leading equipment for non-invasive registration of nerve cell activity using magnetoencephalography (MEG) technology to the new CEA facility - NeuroSpin in Saclay, France, one of the largest research sites for brain imaging in Europe.
Read More ...

 
18-02-2008
Elekta signs agreement to acquire CMS
Elekta AB (publ) (STO:EKTAb) a world leader in clinical solutions for radiation therapy and radiosurgery, today announced that it has signed a purchase agreement to acquire CMS Inc. for a total cash consideration representing an enterprise value of USD 75 M. Closing of the transaction is expected in March.
Read More ...

 
13-02-2008
First Clinical Volumetric Modulated Arc Therapy Treatment Completed with Elekta Synergy® S at General Hospital Vienna
On Thursday, January 31, General Hospital Vienna successfully completed its first Volumetric Modulated Arc Therapy (VMAT)* treatment. The hospital is one of the first in the world to carry out this innovative cancer treatment option.
Read More ...

 
11-02-2008
Elekta chosen to deliver Sophisticated Brain Mapping Technology to the Nebraska Medical Center
Elekta Neuromag®, the world-leading equipment for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology, has been ordered by The Nebraska Medical Center in Omaha, USA.
Read More ...

 
04-02-2008
First patients treated with Elekta VMAT – a major advance in radiation therapy treatments
Patients at the Royal Marsden Hospital in Sutton UK and Allgemeines KrankenHaus / Medical University of Vienna in Austria have successfully completed the world’s first image guided intensity modulated arc therapy treatments using commercially released product solutions.
Read More ...

 
21-01-2008
Elekta to supply CHU de Poitiers Hospital Center in France with Advanced Technology for Image Guided Radiation Therapy
CHU (University Hospital Center) de Poitiers has selected Elekta as the main partner in an ambitious program to improve radiation therapy treatment capacity in the Poitou-Charente region. Replacing equipment from a different vendor, the hospital recently assigned Elekta to deliver three Elekta Synergy® digital linear accelerator systems for intensity modulated and image guided radiation therapy. The order is valued at close to EUR 5 M.
Read More ...

 
10-01-2008
Elekta displays innovative cancer treatment solutions at JASTRO 2007
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, demonstrated a very strong presence at the 20th annual meeting of the Japanese Society for Therapeutic Radiology and Oncology (JASTRO). With over 1,800 radiation oncologists and radiation therapists in attendance, JASTRO was held December 13-15, 2007 at the Fukuoka Convention Center.
Read More ...

 
10-01-2008
Elekta announces clinical start-up of Elekta Synergy® S at UPMC
Treatments have commenced on the new Elekta Synergy® S at University of Pittsburgh Medical Center (UPMC).UPMC is a world-leading provider of intra- and extracranial stereotactic radiosurgery.
Read More ...

 
08-01-2008
Elekta negotiates to acquire CMS
Acquisition of leading treatment planning software developer would strengthen Elekta’s offering and accelerate the company’s expansion into high growth oncology informatics
Read More ...

 
13-11-2007
Belgian cancer patients to receive state-of-the-art radiation therapy treatments with new technology from Elekta
Elekta, a world leader in clinical solutions for radiation therapy and radiosurgery for cancer and brain disorders, have received an order to supply advanced radiation therapy technology and information management software to the University of Liège Hospital (CHU Liège ). The order is valued at more than EUR 3 M and installation is scheduled to begin in March 2008.
Read More ...

 
30-10-2007
Beaumont Hospital, Royal Oak treats its first patients with Elekta Axesse™
Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first treatments using the new Elekta Axesse™, the ultimate whole-body cancer treatment system. Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumor targeting accuracy. The new robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumor targeting.
Read More ...

 
29-10-2007
Elekta announces Elekta Infinity – a new System for Faster, more precise Treatment of Cancer Tumors
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, announced Elekta Infinity*, the definitive new digital linear accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment delivered in single or multiple arcs, at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being held October 28-November 1, at the Los Angeles Convention Center.
Read More ...

 
27-10-2007
IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) and Elekta AB (publ) (Stockholm, Sweden: EKTA.ST), edtoday announced a global particle therapy collaboration program to optimize the seamless integration of proton therapy delivery and information management systems within the radiation oncology environment. Both companies currently showcase their products at the 49th Annual Meeting of ASTRO (American Society for Therapeutic Radiology and Oncology) held in Los Angeles, CA, USA, from October 28 to November 1, 2007.
Read More ...

 
23-10-2007
Elekta announces clinical start-up of new Leksell Gamma Knife® Perfexion™ at UPMC
UPMC Presbyterian’s Center for Image-Guided Neurosurgery, a leading radiosurgery center in the U.S., successfully has commenced patient treatments with Leksell Gamma Knife® Perfexion™ from Elekta.
Read More ...

 
18-10-2007
Elekta announces new Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, will feature advances in cancer care at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO) that dramatically reduce treatment times and increase efficiency. The meeting will be held October 28 - November 1 at the Los Angeles Convention Center (Los Angeles, California, USA). Elekta will showcase innovative offerings that optimize productivity and workflow, empowering health care professionals to spend more time on patient care. One important highlight will be the announcement of a new Elekta solution for clinical Volumetric Intensity Modulated Arc Therapy* (VMAT) that more precisely targets tumors and protects surrounding healthy tissue, while drastically reducing radiation therapy treatment times.
Read More ...

 
12-10-2007
Finding hope for Autism – new Brain Research Technology Centre Opened by HRH Princess Anne
The Oxford Neurodevelopmental Magnetoencephalography (MEG) Centre, featuring advanced new Elekta Neuromag® technology for the investigation of autism, has been officially opened today at the University Department of Psychiatry, Warneford Hospital, in Oxford, United Kingdom by HRH Princess Anne, The Princess Royal.
Read More ...

 
10-10-2007
Niguarda Hospital in Milan, Italy, will commence Stereotactic Radiosurgery Treatments with Leksell Gamma Knife® Perfexion™ from Elekta
In September, Elekta received an order from the highly prestigious Niguarda Hospital for Leksell Gamma Knife® Perfexion™, the latest and most advanced system available for stereotactic radiosurgery. The system will be installed in October and inauguration is planned for mid-November.
Read More ...

 
28-09-2007
Elekta wins tender to supply new hospital in Austria with Comprehensive Solution for Advanced Radiation Therapy
Elekta today announced an order from Vöcklabruck Hospital in the region of Upper Austria. Valued at approx. EUR 5 M, the 10-year agreement includes supplying a brand new oncology department with fully digital IMRT and IGRT treatment systems, as well as software for networking, information management and treatment planning.
Read More ...

 
26-09-2007
Elekta selected to supply Advanced Radiation Therapy Capability to Greece’s largest Private Hospital
Elekta, a world leader in advanced radiation therapy and radiosurgery has been awarded a Contract by the Diagnostic and Therapeutic Center of Athens – HYGEIA S.A. – to supply and install three linear accelerator systems, including one Elekta Axesse™ stereotactic image guided treatment system, a comprehensive network and information management system and a long-term service contract. The Contract is valued at over EUR 8 M.
Read More ...

 
25-09-2007
Two new Italian Cancer Centers select Advanced Radiation Treatment Technology from Elekta
Elekta has been selected by two progressive Italian hospitals opening up new radiation therapy clinics, to supply advanced and clinically proven cancer treatment systems for intensity modulated and image guided radiation therapy (IMRT & IGRT). The two clinics will play an important role in their respective region to provide first class radiation therapy and to increase cancer treatment capacity.
Read More ...

 
12-09-2007
Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
Elekta is pleased to announce the development of a comprehensive solution for planning and performing Volumetric Intensity Modulated Arc Therapy (VMAT)*. The complete offering of Elekta VMAT solutions are being featured in the Elekta booth at this year’s European Society of Therapeutic Radiation Oncologists (ESTRO) meeting in Barcelona, September 8-13, 2007. Performing VMAT with Elekta enables helical-like conformality and can help reduce total treatment time even with daily use of Elekta’s proven X-ray Volume Imaging system.
Read More ...

 
11-09-2007
Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
Elekta is showcasing its motion management systems at this year's European Society of Therapeutic Radiation Oncologists (ESTRO), held September 8-13, 2007, at the Palau de Congresos de Catalunya in Barcelona, Spain. Elekta will highlight innovative solutions for motion management and patient positioning at the Elekta booth No. 4-6.
Read More ...

 
10-09-2007
Elekta Launches new Linear Accelerator at 2007 ESTRO to expand Cancer Treatment Availability
Elekta today unveiled a new member of the Elekta family of linear accelerators at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2007 meeting. At an unveiling ceremony in the Elekta booth, Elekta President & CEO Tomas Puusepp announced the launch of Elekta Compact™, a new addition to Elekta's product line of linear accelerators that offers an easy to implement, more affordable solution for radiation therapy.
Read More ...

 
06-09-2007
Elekta to Showcase Innovations in Radiotherapy and unveil new Product that Expands Cancer Treatment Availability
Elekta, a world leader in radiation oncology and non-invasive neurosurgery solutions, will showcase the latest advances in radiotherapy, stereotactic radiosurgery and clinical workflow solutions at the European Society of Therapeutic Radiation Oncologists (ESTRO) 2007 meeting in Barcelona, Spain, September 8-13.
Read More ...

 
03-09-2007
Elekta demonstrates commitment to stereotactic innovation at EANS
Leading neurosurgical device developer Elekta will feature the newest advances in neurosurgical diagnostic and treatment devices, along with clinical workflow solutions that make neurosurgery more effective and efficient at the European Association of Neurosurgical Societies (EANS) European Congress September 2-7, 2007. More than 1,000 neurosurgeons and related medical professionals will gather at the Scottish Exhibition & Conference Centre in Glasgow for the event.
Read More ...

 
21-08-2007
Arden Cancer Center better able to respond to the needs of Palliative Care with Integrated Software Solution from Elekta
The Palliative Care Team at Arden Cancer Center, part of the University Hospitals Coventry & Warwickshire NHS Trust, guarantee patient data security as part of the implementation of IMPAC Electronic Medical Record software from Elekta.
Read More ...

 
14-08-2007
Barnes-Jewish Hospital upgrades Radiosurgery Capabilities with Leksell Gamma Knife® Perfexion™
The highly respected Barnes-Jewish Hospital has placed an order for Leksell Gamma Knife® Perfexion™, the most advanced system for noninvasive radiosurgery in the world.
Read More ...

 
10-08-2007
Elekta to deliver Leksell Gamma Knife® to St. Petersburg, Russia
Elekta today announced an order to deliver a Leksell Gamma Knife® 4C, to a new hospital under construction in St. Petersburg, Russia, that will become the second hospital in Russia to offer non-invasive radiosurgery for tumors and other brain disorders.
Read More ...

 
26-07-2007
Illinois Neurological Institute at Saint Francis Medical Center Upgrades to Leksell Gamma Knife® Perfexion™
The Illinois Neurological Institute (INI) at OSF Saint Francis Medical Center will soon install Leksell Gamma Knife® Perfexion™, the most advanced system for non-invasive radiosurgery. A revolutionary alternative to traditional open-brain surgery and daily radiation treatments, Leksell Gamma Knife Perfexion uses focused doses of radiation without making a single incision to treat malignant and benign brain tumors, as well as, other brain disorders.
Read More ...

 
23-07-2007
Elekta and IMPAC to Highlight Cancer Treatment Solutions During AAPM Annual Meeting
At this year’s American Association of Physicists in Medicine (AAPM) annual meeting, Elekta will showcase their unique cancer treatment solutions to the market, by demonstrating how the joint forces of Elekta and IMPAC Medical Systems help physicians in the fight against cancer.
Read More ...

 
06-07-2007
Cancer Patients in New South Wales, Australia to receive Advanced Image Guided Radiation Therapy Treatments with arrival of new Elekta Linear Accelerators
North Coast Cancer Institute (NCCI) Coffs Harbour and Port Macquarie began providing radiotherapy treatment services for the first time in the North Coast region of New South Wales, Australia.
Read More ...

 
29-06-2007
Elekta Selected to supply the Royal Marsden Hospital in London, UK, with Additional Advanced Radiation Therapy Systems
Elekta, a world leader in advanced radiation therapy and radiosurgery treatments, has recently been awarded an order to supply two Elekta Synergy® systems to The Royal Marsden NHS Foundation Trust. Included within the order is one HexaPOD™ 6D robotic patient positioning system and a full MOSAIQ™ electronical medical records and networking software suite.
Read More ...

 
18-06-2007
Leksell Gamma Knife® Perfexion™ Setting New Standards for Fast, Effective, Precise Radiosurgery Treatments
One year after the first Leksell Gamma Knife® Perfexion™ treatment was performed in Marseille, France, the revolutionary radiosurgery system is exceeding expectations and delivering fast, effective, precise radiosurgery treatments and to date, has treated more than 300 patients. Physicians now have an unprecedented ability to develop and deliver complex treatment plans for patients with metastatic brain tumors.
Read More ...

 
10-05-2007
New Gamma Knife Center in Lisbon, Portugal, orders Leksell Gamma Knife® Perfexion™ from Elekta
Elekta today announced an order for Leksell Gamma Knife® Perfexion™, the latest and most advanced system ever for non-invasive radiosurgery of brain disorders, from Centro Gamma Knife Radiocirurgia S.A. This first Gamma Knife Center in Portugal will be established at Hospital CUF Infante Santo, a part of the Jose Mello-Saude Group.
Read More ...

 
04-05-2007
Elekta to supply leading IGRT solution to Vejle Hospital in Denmark
Vejle hospital has selected Elekta to supply world leading technology for intensity modulated and image guided radiation therapy and two Elekta Synergy® systems will be installed during 2007 and 2008. Elekta Synergy allows the clinicians to visualize the target at the time of treatment, enabling more aggressive treatment of tumors with increased precision and accuracy while minimizing the risk of damage to surrounding healthy tissue. The order is valued at over SEK 30 M.
Read More ...

 
02-05-2007
Elekta receives order to deliver the first Leksell Gamma Knife® Perfexion™ to India
Elekta today announced a new order from India for Leksell Gamma Knife® Perfexion™, the world's most advanced system for non-invasive radiosurgery of brain disorders including tumors, brain metastases and functional disorders. The purchase decision is an important step in the effort to improve quality and capacity of treatment of brain diseases for the entire northern part of India. The order also demonstrates that Elekta has earned a strong reputation in one of the most interesting emerging markets in the world as a company with state-of-the-art technology and clinical solutions for treatment of cancer and brain disorders.
Read More ...

 
23-03-2007
Elekta Acquires 3D Line Medical Systems
Elekta, world leader in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, today announced the acquisition of 3D Line Medical Systems S.r.l. Through this acquisition, Elekta adds a highly qualified R&D group specialized in stereotactic radiosurgery and dynamic IMRT treatments as well as a product portfolio of advanced equipment and treatment planning software systems for performing radiation therapy with extreme precision and optimized dose distribution.
Read More ...

 
09-03-2007
University of Tokyo Hospital Commence Treatment with Japan’s First System for Advanced Image Guided Radiation Therapy
After becoming Japan’s first medical center to acquire Elekta Synergy®, an advanced treatment system for intensity modulated and image guided radiation therapy (IMRT and IGRT), University of Tokyo Hospital recently treated its first patients, becoming the first hospital in Japan to clinically use advanced, 3D X-ray volume image guided radiation therapy to irradiate cancer tumors with higher precision and accuracy.
Read More ...

 
14-02-2007
Welsh Cancer Patients to Benefit from Investment in Latest Cancer Treatment Technology at Velindre Cancer Center
Velindre Cancer Center in Cardiff, Wales, are to introduce advanced radiation therapy solutions from spring 2007 in the form of medical equipment and software. The first system supplied by Sussex based Elekta Limited, will be on-line to commence treatment of patients in early 2008. This will be followed by a second unit, also from Elekta, scheduled to be introduced into service later that year.
Read More ...

 
05-01-2007
Elekta to deliver Leksell Gamma Knife® Perfexion™ to UPMC
One of the U.S. premier providers of Gamma Knife® surgery, The University of Pittsburgh Medical Center-Presbyterian (UPMC) in Pittsburgh, has agreed to purchase the new Leksell Gamma Knife® Perfexion™ , the most advanced system ever for non-invasive radiosurgery of brain disorders. UPMC will be one of the first medical centers in the country to install this new system in the early spring of 2007.